Conclusion

Jump to section

• Overview & contents
• i. Important Notice
• 1. Executive Summary
• 2. The South African Egg Market
• 3. Avian Influenza: The Risk That Defines This Business
• 4. SWOT and Competitive Position
• 5. The Five-Stage Roadmap
• 6. The Funding Ladder
• 7. Flock Performance
• 8. Feed Strategy
• 9. Point-of-Lay Pullet Sourcing
• 10. Biosecurity
• 11. Route to Market and Pricing
• 12. Operations and People
• 13. Regulation and Compliance
• 14. Unit Economics
• 15. Capital Expenditure
• 16. Financial Projections
• 17. Break-Even
• 18. Sensitivity and the Grant Question
• 19. Risk Management
• 20. Implementation Roadmap
• 21. Returns
• 22. Key Performance Indicators
• 23. Key Assumptions
• 24. Conclusion
• A. Appendix A: Consolidated Financial Summary
• B. Appendix B: Stage Capital Schedules
• C. Appendix C: Debt Schedules
• D. Appendix D: Risk Register
• E. Appendix E: Funding Application Checklist
• F. Appendix F: Glossary

Khanya Eggs is a commercial layer enterprise that reaches 30 000 birds, 6.18 million eggs and R5.06 million of EBITDA by Year 5 on R13.53 million of capital deployed across five separately funded stages. The founder’s own cash requirement is R450 000.

The plan rests on three observations. Below roughly 7 400 hens in lay at the mature cost base this is not a business, and the farm crosses its own contemporaneous break-even during Year 3, which makes Stages 1 and 2 a funded apprenticeship rather than a commercial operation, and makes the track record they produce the most valuable thing built in those two years. Avian influenza is uninsured, uncompensated and recent, which is why the capital programme builds eight houses instead of two and funds biosecurity before it funds capacity. And the direct sales channel is what makes the margin work, which is why the plan models the blended price as flat in nominal terms as the mix shifts into wholesale rather than escalating it and overstating Year 5 revenue by some R4.5 million.

The staging is the strategy. A first-time farmer asking for R13.53 million will be declined; the same farmer asking for R950 000 against a documented 500-bird operation is fundable, and two years later, holding production records, reviewed financials and a repayment history, is a different applicant entirely. Each of the five gates asks only for what a funder would demand anyway, which means the entrepreneur is never applying for capital they cannot justify and never operating beyond what they can run.

R3.65 million of the programme is targeted grant funding, and none of it is committed. The plan is deliberately built so that grant failure delays it rather than ends it: with every rand of grant replaced by an 11 per cent commercial loan, Year 5 debt rises to R12.24 million and profit after tax falls to R2.27 million, but EBITDA still covers debt service 3.23 times against a 1.5 times gate. What the grants buy is speed, headroom and a better outcome for the founder, not viability.

A funder should assess this transaction on the 37.4 per cent return on capital deployed, the 2.7-year payback, the 5.42 times debt service cover and the fact that every scenario tested in Section 18 leaves the business comfortably EBITDA positive at Year 5 scale. The founder’s forty-five times money multiple is arithmetically correct and describes South Africa’s blended finance architecture rather than the quality of this particular farm.